Organogenesis(ORGO)

11.045 -0.045 -0.4058%

今开:11.11昨收:11.09
最高:11.17 最低:10.93
涨停价:0.0跌停价:0.0
总市值:1.420208082E9

Organogenesis的热门评论

7X24快讯05-27 22:29

ORGANOGENESIS(ORGO.O)涨超12%,该股将加入标普小盘600指数。查看全文

Organogenesis(ORGO)05-11 04:42

$Organogenesis(ORGO)$ 8-K Current report, items 1.01, 2.02, 5.02, and 9.01 Accession Number: 0001193125-21-156247 Act: 34 Size: 240 KB 网页链接查看全文

7X24快讯05-27 05:20

标普道琼斯指数公司:卡骆驰(CROX.O)将加入标普中盘400指数,ORGANOGENESIS(ORGO.O)将加入标普小盘600指数。查看全文

Organogenesis(ORGO)05-19 05:51

$Organogenesis(ORGO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-21-017917 Act: 34 Size: 250 KB 网页链接查看全文

Dreamland202003-22 22:53

$Organogenesis(ORGO)$ 一个月前在13块的时候就犹豫要不要买,觉得等跟着大盘回落再买比较好,结果等到了今天。买了一点看看后市如何表现吧查看全文

纳指去年涨幅创十年之最,2021年能否续写辉煌?

美股研究社01-06 17:57

本文作者:Sanghamitra Saha 2020年第四季度,乐观情绪席卷了整个市场,标普500指数和道琼斯指数在今年收盘时均创下新高。尽管COVID-19带来了挑战,但可观的收益发布、2021年经济复苏的希望、疫苗方面的积极进展以及超宽松的全球货币政策在2020年帮助了市场。 不过,科技股占主导地位的纳斯达克指...查看全文

Organogenesis(ORGO)08-20 08:33

$Organogenesis(ORGO)$ 内部交易: 2021-08-17,10% Owner,KATZ MICHAEL W ,买入,12000普通股, $13.55查看全文

持股变动声明

Organogenesis(ORGO)08-20 07:42

$Organogenesis(ORGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001661181-21-000066 Size: 4 KB 网页链接查看全文

当期报告

Organogenesis(ORGO)08-17 04:48

$Organogenesis(ORGO)$ 8-K Current report, items 1.01, 1.02, and 9.01 Accession Number: 0001193125-21-247828 Act: 34 Size: 223 KB 网页链接查看全文

持股变动声明

Organogenesis(ORGO)08-06 06:30

$Organogenesis(ORGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001661181-21-000064 Size: 4 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Organogenesis的最新评论

Organogenesis(ORGO)2019-08-10 04:45

$Organogenesis(ORGO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-09 AccNo: 0001193125-19-217411 Size: 5 MB 网页链接查看全文

Organogenesis(ORGO)2019-08-10 04:45

$Organogenesis(ORGO)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001193125-19-217408 Size: 19 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Organogenesis(ORGO)2019-08-10 04:45

$Organogenesis(ORGO)$ SC TO-I/A [Amend] - Tender offer statement by Issuer Filed: 2019-08-09 AccNo: 0001193125-19-218019 Size: 78 KB 网页链接查看全文

Organogenesis(ORGO)2019-08-09 05:30

$Organogenesis(ORGO)$ 8-K - Current report Filed: 2019-08-08 AccNo: 0001193125-19-216961 Size: 80 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Organogenesis(ORGO)2019-07-31 07:35

$Organogenesis(ORGO)$ 美东时间 2019-08-09 盘前 披露财报,预期EPS -0.13 网页链接查看全文

Organogenesis(ORGO)2019-07-23 13:20

$Organogenesis(ORGO)$ DEF 14A - Other definitive proxy statements Filed: 2019-07-22 AccNo: 0001193125-19-199020 Size: 383 KB 网页链接查看全文

Organogenesis(ORGO)2019-07-23 13:20

$Organogenesis(ORGO)$ SC TO-I/A [Amend] - Tender offer statement by Issuer Filed: 2019-07-22 AccNo: 0001193125-19-199027 Size: 661 KB 网页链接查看全文

Organogenesis(ORGO)2019-07-17 02:30

$Organogenesis(ORGO)$ SC TO-C - Written communication relating to an issuer or third party Filed: 2019-07-16 AccNo: 0001193125-19-194344 Size: 43 KB 网页链接查看全文

Organogenesis(ORGO)2019-07-17 02:30

$Organogenesis(ORGO)$ 8-K - Current report Filed: 2019-07-16 AccNo: 0001193125-19-194343 Size: 43 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Organogenesis(ORGO)2019-07-13 14:10

$Organogenesis(ORGO)$ PRE 14A - Other preliminary proxy statements Filed: 2019-07-12 AccNo: 0001193125-19-193315 Size: 379 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Organogenesis的公告

$Organogenesis(ORGO)$ 内部交易: 2021-08-17,10% Owner,KATZ MICHAEL W ,买入,12000普通股, $13.55

持股变动声明

$Organogenesis(ORGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001661181-21-000066 Size: 4 KB 网页链接

当期报告

$Organogenesis(ORGO)$ 8-K Current report, items 1.01, 1.02, and 9.01 Accession Number: 0001193125-21-247828 Act: 34 Size: 223 KB 网页链接

季度财报

$Organogenesis(ORGO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-21-240472 Act: 34 Size: 7 MB 网页链接

当期报告

$Organogenesis(ORGO)$ 8-K Current report, items 1.01, 1.02, 2.02, 2.03, 7.01, and 9.01 Accession Number: 0001193125-21-240438 Act: 34 Size: 1 MB 网页链接

持股变动声明

$Organogenesis(ORGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001661181-21-000064 Size: 4 KB 网页链接

$Organogenesis(ORGO)$ 内部交易: 2021-07-19,总裁 and CEO,Gillheeney Gary S. ,卖出,160237普通股, $14.02

$Organogenesis(ORGO)$ 内部交易: 2021-07-16,总裁 and CEO,Gillheeney Gary S. ,卖出,139763普通股, $14.74

$Organogenesis(ORGO)$ 内部交易: 2021-07-16,总裁 and CEO,Gillheeney Gary S. ,期权,139763普通股, $3.51

$Organogenesis(ORGO)$ 内部交易: 2021-07-19,总裁 and CEO,Gillheeney Gary S. ,期权,160237普通股, $0.99

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22